Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing

Sofia R. Gameiro, Anthony S. Malamas, Michael B. Bernstein, Kwong Y. Tsang, April Vassantachart, Narayan Sahoo, Ramesh Tailor, Rajesh Pidikiti, Chandan Guha, Stephen M. Hahn, Sunil Krishnan, James W. Hodge

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Purpose To provide the foundation for combining immunotherapy to induce tumor antigen-specific T cells with proton radiation therapy to exploit the activity of those T cells. Methods and Materials Using cell lines of tumors frequently treated with proton radiation, such as prostate, breast, lung, and chordoma, we examined the effect of proton radiation on the viability and induction of immunogenic modulation in tumor cells by flow cytometric and immunofluorescent analysis of surface phenotype and the functional immune consequences. Results These studies show for the first time that (1) proton and photon radiation induced comparable up-regulation of surface molecules involved in immune recognition (histocompatibility leukocyte antigen, intercellular adhesion molecule 1, and the tumor-associated antigens carcinoembryonic antigen and mucin 1); (2) proton radiation mediated calreticulin cell-surface expression, increasing sensitivity to cytotoxic T-lymphocyte killing of tumor cells; and (3) cancer stem cells, which are resistant to the direct cytolytic activity of proton radiation, nonetheless up-regulated calreticulin after radiation in a manner similar to non-cancer stem cells. Conclusions These findings offer a rationale for the use of proton radiation in combination with immunotherapy, including for patients who have failed radiation therapy alone or have limited treatment options.

Original languageEnglish (US)
Pages (from-to)120-130
Number of pages11
JournalInternational Journal of Radiation Oncology Biology Physics
Volume95
Issue number1
DOIs
StatePublished - May 1 2016

Fingerprint

Photons
Protons
tumors
signatures
Radiation
T-Lymphocytes
modulation
antigens
protons
photons
radiation
Calreticulin
Neoplasms
Neoplasm Antigens
stem cells
Immunotherapy
Radiotherapy
radiation therapy
Proton Therapy
Chordoma

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. / Gameiro, Sofia R.; Malamas, Anthony S.; Bernstein, Michael B.; Tsang, Kwong Y.; Vassantachart, April; Sahoo, Narayan; Tailor, Ramesh; Pidikiti, Rajesh; Guha, Chandan; Hahn, Stephen M.; Krishnan, Sunil; Hodge, James W.

In: International Journal of Radiation Oncology Biology Physics, Vol. 95, No. 1, 01.05.2016, p. 120-130.

Research output: Contribution to journalArticle

Gameiro, Sofia R. ; Malamas, Anthony S. ; Bernstein, Michael B. ; Tsang, Kwong Y. ; Vassantachart, April ; Sahoo, Narayan ; Tailor, Ramesh ; Pidikiti, Rajesh ; Guha, Chandan ; Hahn, Stephen M. ; Krishnan, Sunil ; Hodge, James W. / Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. In: International Journal of Radiation Oncology Biology Physics. 2016 ; Vol. 95, No. 1. pp. 120-130.
@article{28d972d9bfe04485ab4398326d108b56,
title = "Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing",
abstract = "Purpose To provide the foundation for combining immunotherapy to induce tumor antigen-specific T cells with proton radiation therapy to exploit the activity of those T cells. Methods and Materials Using cell lines of tumors frequently treated with proton radiation, such as prostate, breast, lung, and chordoma, we examined the effect of proton radiation on the viability and induction of immunogenic modulation in tumor cells by flow cytometric and immunofluorescent analysis of surface phenotype and the functional immune consequences. Results These studies show for the first time that (1) proton and photon radiation induced comparable up-regulation of surface molecules involved in immune recognition (histocompatibility leukocyte antigen, intercellular adhesion molecule 1, and the tumor-associated antigens carcinoembryonic antigen and mucin 1); (2) proton radiation mediated calreticulin cell-surface expression, increasing sensitivity to cytotoxic T-lymphocyte killing of tumor cells; and (3) cancer stem cells, which are resistant to the direct cytolytic activity of proton radiation, nonetheless up-regulated calreticulin after radiation in a manner similar to non-cancer stem cells. Conclusions These findings offer a rationale for the use of proton radiation in combination with immunotherapy, including for patients who have failed radiation therapy alone or have limited treatment options.",
author = "Gameiro, {Sofia R.} and Malamas, {Anthony S.} and Bernstein, {Michael B.} and Tsang, {Kwong Y.} and April Vassantachart and Narayan Sahoo and Ramesh Tailor and Rajesh Pidikiti and Chandan Guha and Hahn, {Stephen M.} and Sunil Krishnan and Hodge, {James W.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ijrobp.2016.02.022",
language = "English (US)",
volume = "95",
pages = "120--130",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing

AU - Gameiro, Sofia R.

AU - Malamas, Anthony S.

AU - Bernstein, Michael B.

AU - Tsang, Kwong Y.

AU - Vassantachart, April

AU - Sahoo, Narayan

AU - Tailor, Ramesh

AU - Pidikiti, Rajesh

AU - Guha, Chandan

AU - Hahn, Stephen M.

AU - Krishnan, Sunil

AU - Hodge, James W.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose To provide the foundation for combining immunotherapy to induce tumor antigen-specific T cells with proton radiation therapy to exploit the activity of those T cells. Methods and Materials Using cell lines of tumors frequently treated with proton radiation, such as prostate, breast, lung, and chordoma, we examined the effect of proton radiation on the viability and induction of immunogenic modulation in tumor cells by flow cytometric and immunofluorescent analysis of surface phenotype and the functional immune consequences. Results These studies show for the first time that (1) proton and photon radiation induced comparable up-regulation of surface molecules involved in immune recognition (histocompatibility leukocyte antigen, intercellular adhesion molecule 1, and the tumor-associated antigens carcinoembryonic antigen and mucin 1); (2) proton radiation mediated calreticulin cell-surface expression, increasing sensitivity to cytotoxic T-lymphocyte killing of tumor cells; and (3) cancer stem cells, which are resistant to the direct cytolytic activity of proton radiation, nonetheless up-regulated calreticulin after radiation in a manner similar to non-cancer stem cells. Conclusions These findings offer a rationale for the use of proton radiation in combination with immunotherapy, including for patients who have failed radiation therapy alone or have limited treatment options.

AB - Purpose To provide the foundation for combining immunotherapy to induce tumor antigen-specific T cells with proton radiation therapy to exploit the activity of those T cells. Methods and Materials Using cell lines of tumors frequently treated with proton radiation, such as prostate, breast, lung, and chordoma, we examined the effect of proton radiation on the viability and induction of immunogenic modulation in tumor cells by flow cytometric and immunofluorescent analysis of surface phenotype and the functional immune consequences. Results These studies show for the first time that (1) proton and photon radiation induced comparable up-regulation of surface molecules involved in immune recognition (histocompatibility leukocyte antigen, intercellular adhesion molecule 1, and the tumor-associated antigens carcinoembryonic antigen and mucin 1); (2) proton radiation mediated calreticulin cell-surface expression, increasing sensitivity to cytotoxic T-lymphocyte killing of tumor cells; and (3) cancer stem cells, which are resistant to the direct cytolytic activity of proton radiation, nonetheless up-regulated calreticulin after radiation in a manner similar to non-cancer stem cells. Conclusions These findings offer a rationale for the use of proton radiation in combination with immunotherapy, including for patients who have failed radiation therapy alone or have limited treatment options.

UR - http://www.scopus.com/inward/record.url?scp=84963553844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963553844&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2016.02.022

DO - 10.1016/j.ijrobp.2016.02.022

M3 - Article

C2 - 27084634

AN - SCOPUS:84963553844

VL - 95

SP - 120

EP - 130

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -